Vaccine Manufacturing Congress is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Alexander (Sandy) Douglas
Principal Investigator at Nuffield Department of Medicine, University of Oxford


Dr Alexander Douglas is an academic physician based at the Jenner Institute, University of Oxford. He is leading development of a new simian adenovirus-vectored vaccine against rabies. He is also a co-investigator in the Oxford / University College London co-ordinated Future Vaccine Manufacturing Research Hub. He will present results from Oxford's research within the Hub with a particular focus upon GMP manufacture of simian adenoviruses for early-phase clinical trials. He will discuss a rapid and robust process applicable to manufacture of adenoviruses of diverse serotypes and with diverse transgenes, using entirely single-use product-contact materials.

Alexander (Sandy) Douglas's Network

Agenda Sessions

  • Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector

    , 12:10